Department of Orthopedics, Tongde Hospital of Zhejiang Provincial, Zhejiang Academy of Traditional Chinese Medicine, No. 234 Gucui Road, Hangzhou, 310002, Zhejiang, People's Republic of China.
Institute of Cancer Research and Basic Medical Sciences, Cancer Hospital of University Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
J Orthop Surg Res. 2021 May 27;16(1):341. doi: 10.1186/s13018-021-02496-1.
To investigate the clinical effect of gastrocnemius muscle flaps combined with vancomycin/gentamicin-calcium sulfate combined and autologous iliac bone graft in the phase I treatment of traumatic focal osteomyelitis (Cierny-Mader type III) after tibial plateau fracture surgery.
From July 2009 to January 2018, 35 patients with localized osteomyelitis (Cierny-Mader type III) who met the inclusion criteria were followed up and treated. All patients were infected after undergoing internal fracture fixation surgery. Among them, 18 cases were plate-exposed, 14 cases were due to sinus tracts, two were due to skin necrosis, and one was bone-exposed. We treated patients with several measures. All cases were then followed up. The follow-up indicators included Hospital for Special Surgery knee scores (HSS), the time of laying drainage pipe, bone healing time, infection control rate, and the incidence of nonunion and other complications.
All patients were followed up for 24-60 months. None of them underwent amputation. For repairing soft tissue defects, 17 cases were covered with a muscle flap using the medial head of gastrocnemius alone, 15 cases were treated with the lateral head of gastrocnemius muscle, and three cases were covered with the combination of the two heads. Compared to the preoperative score, we found that the average HSS improved at the 1-year and 2-year follow-up (54 vs. 86 vs. 87).
Using a gastrocnemius muscle flap combined with vancomycin/gentamicin-calcium sulfate and autogenous iliac bone was an effective method for the phase I treatment of osteomyelitis (Cierny-Mader type III) after tibial plateau fracture surgery. In the primary treatment of focal traumatic osteomyelitis, it can decrease the treatment time, number of surgeries, pain of patients, time of bone healing, postoperative exudation, and infection recurrence rate and increase the healing bone's strength.
探讨腓肠肌肌皮瓣联合万古霉素/庆大霉素-硫酸钙及自体髂骨移植在胫骨平台骨折术后创伤性局限性骨髓炎(Cierny-Mader Ⅲ型)Ⅰ期治疗中的临床疗效。
2009 年 7 月至 2018 年 1 月,对符合纳入标准的 35 例局限性骨髓炎(Cierny-Mader Ⅲ型)患者进行随访治疗,均为骨折内固定术后感染,其中钢板外露 18 例,窦道形成 14 例,皮肤坏死 2 例,骨外露 1 例。采用多种方法治疗患者,所有患者均获得随访,随访指标包括美国特种外科医院膝关节评分(HSS)、置管引流时间、骨愈合时间、感染控制率、骨不连等并发症发生率。
所有患者均获得 24~60 个月随访,均未截肢。修复软组织缺损,腓肠肌内侧头肌皮瓣 17 例,腓肠肌外侧头肌皮瓣 15 例,双肌皮瓣 3 例。与术前相比,术后 1 年、2 年 HSS 平均评分均有改善(54 分比 86 分比 87 分)。
腓肠肌肌皮瓣联合万古霉素/庆大霉素-硫酸钙及自体髂骨是胫骨平台骨折术后骨髓炎(Cierny-Mader Ⅲ型)Ⅰ期治疗的有效方法,在创伤性局限性骨髓炎的初步治疗中,可减少治疗时间、手术次数、患者疼痛、骨愈合时间、术后渗出、感染复发率,增加愈合骨的强度。